The study has been recently published on Nature Communications and is co-authored by Prof. Raffaella Bonecchi. According to...
Staff Scientist of the Gastrointestinal Immunopathology Laboratory at Humanitas Research Hospital
Delegate of the Rector for the disability and DSA in Humanitas University
Education and Academic Background
Stefania Vetrano completed her Bachelor’s degree in Biological Sciences in 2002 and in Clinical Pathology in 2010 at the University “La Sapienza of Rome”. In 2010 achieved her PhD in Experimental pathology and neuropathology at the University of Milan. She worked for 5 years on the pathogenesis and screening of celiac disease, and spent a period in King’s College University of London to study the innate immune response in patients with celiac disease. Since 2006 she has been working as researcher and staff scientist in the laboratory of gastrointestinal immunopathology at the Humanitas Clinical and Research Center of Rozzano, Milan. 2015 to now she is assistant professor in applied biology at the Humanitas University, and starting from 2016 she is a delegate of the rector for the disability and DSA.
She actively collaborates with other national and international university (University of Chicago,USA; Notre Dame University, USA; Research Center “Alexander Fleming” in Athens; Friedrich-Alexander University, Erlangen (Germany).
Scientific and Research Interests
Her studies are devoted to understand the complex interplay between non-immune cells and environmental factors in the pathogenesis of inflammatory bowel disease (IBD) and intestinal tumorigenesis. She mostly focused her interest on the role of intestinal epithelial and endothelial cells; and mesenchymal cells. Her studies aim not only at shedding light on the molecular mechanisms underlying intestinal inflammatory processes in IBD patients, but also at exploring new therapeutic targets that could pave the way for new therapeutic approaches for the treatment of IBD and for the prevention of colorectal cancer.
- M Mahapatro, S Foersch, M Hefele, GW He, E Giner-Ventura, T Mchedlidze, M Kindermann, S Vetrano, S Danese, C Günther, MF Neurath, S Wirtz, C Becker. – Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection. Cell Rep. 2016 May 11. pii: S2211-1247(16)30476-4.
- E Sala, M Genua, L Petti, A Anselmo, V Arena, J Cibella, L Zanotti, S D’Alessio, F Scaldaferri, G Luca, I Arato, R Calafiore, A Sgambato, S Rutella, M Locati, S Danese, S Vetrano. – Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. Gastroenterology. 2015 Jul;149(1):163-176.e20. doi: 10.1053/j.gastro.2015.03.013. Epub 2015 Mar 17
- Roulis M, Nikolaou C, Kotsaki E, Kaffe E, Karagianni N, Koliaraki V, Salpea K, Ragoussis J, Aidinis V, Martini E, Becker C, Herschman HR, Vetrano S, Danese S, Kollias G – Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):E4658-67. doi: 10.1073/pnas.1415762111. Epub 2014 Oct 14.
- S Vetrano, VA Ploplis, E Sala, M Sandoval-Cooper, DL Donahue, C Correale, V Arena, A Spinelli, A Repici, A Malesci, FJ Castellino, S Danese. – Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19830-5.
- S Vetrano, EM Borroni, A Sarukhan, B Savino, R Bonecchi, C Correale, V Arena, M Fantini, M Roncalli, A Malesci, A Mantovani, M Locati, S Danese. – The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut. 2010 Feb;59(2):197-206
Academic honors, awards and prizes
- 2006: Price AMICI Piemonte for the project: Role of JAM-A in the transmigration of leukocytes in IBD.
- 2009: Grant from ECCO organization for the project: Protein C pathway in IBD pathogenesis.
- 2011: Grant from ECCO organization for the project: The role of Chemerin /ChemR23 axis in the pathogenesis of IBD.
- 2011: Grant Giovani Ricercatori funded by Ministero della Salute (GR -2009 convenzione 76); Mesenchymal Stem Cells and IBD.
- 2013: Grant funded by Cariplo Foundation; “Junctional Adhesion Molecule-A: a new key regulator in colorectal cancer”.
- 2015: Grant funded by Associazione Italiana Ricerca contro il Cancro (AIRC), for the project: Diet, microbiota, intestinal barrier function and cancer: new insight for novel therapeutic approaches.